• Resize Text
    • Small Text
    • Medium Text
    • Large Text
    • Connect
Cardiovascular System
Cardiovascular System

Bumetanide Oral Solution

Bumetanide is an oral liquid medicine used to treat Oedema.

Bumetanide is indicated for:

Whenever diuretic therapy is required in the treatment of oedema, e.g. that associated with congestive heart failure, cirrhosis of the liver and renal disease including nephrotic syndrome.

Icon respresenting a network

Summary of Product Characteristics

Read this summary of product characteristics for further information about Bumetanide Liquid Oral Solution. Click below to navigate to the EMC.

More info
Icon respresenting a person

Patient Information Leaflet

Read this patient information leaflet about Bumetanide Liquid Oral Solution, what it’s used for and possible side effects. Click below to navigate to the EMC.

More info
Cardiovascular System

Bumetanide Oral Solution

Bumetanide Oral Solution
Click here for Audio Version
Flavour Peppermint
Storage Conditions Store below 25°C
Sucrose Free
Shelf Life (Closed Bottle) 3 years
PIP Code 1142637
EAN Code 5016119000782
Sodium Levels Essentially sodium-free
Ethanol Concentration None

Downloads

Adverse Drug Events

Information about adverse event reporting can be found at www.mhra.gov.uk/yellowcard
Adverse events should also be reported to Rosemont Pharmaceuticals Ltd on 0113 244 1400

Rosemont Pharmaceuticals - World Map icon

Contact us

For further product information and pricing please use the form below and a member of the team will be in touch






    Please prove you are human by selecting the car.

    Stay updated via our App

     

    A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.

    Rosemont app on a mobile device

    Cardiovascular System

    Bumetanide Oral Solution

    Bumetanide Oral Solution